dismiss

The 1st Ever Medical World Americas is in Houston, TX, April 28-30 - Get a Free 1-Day Pass!

SEARCH

Current Location: DOTmed News > Industry Headlines > This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

More Industry Headlines

Doc fix bill puts clinical decision support in the spotlight Appropriateness criteria is the new reality.

False positive results: not as bad as you thought But women will still undergo additional breast cancer tests.

ECRI's top 10 patient safety concerns HIT, care coordination, drug shortages top safety list.

FDA clears new CT system from Siemens Ideal for challenging cases.

FDA OKs Shimadzu's new R/F system For a wide variety of exams.

CT can detect arterial plaque for diabetics CCTA is a welcome development.

Gov. Jan Brewer signs breast density law Arizona becomes the latest state with inform legislation.

Goggles that illuminate cancer cells Could they reduce second surgeries?

Philips suspends CT and PET/CT production at Ohio facility Setback for customers and the company.

Varian's seven year patent dispute comes to an end Company will pay about $35 million.

Courtesy of IBA

CMS won't budge on proton therapy cuts

by Loren Bonner , DOTmed News Online Editor
Medicare reimbursement rates for proton therapy included in the final Hospital Outpatient Prospective Payment System (HOPPS) rule for 2013 reflect significant reductions from 2012.

Specifically, the code for ambulatory surgical center payment systems (APC) in the HOPPS rule that applies to proton treatment "complex" procedures — harder to treat procedures — decreases the mean payment for proton therapy from $1,549 in 2012 down to $682 for 2013.

Story Continues Below Advertisement

OiService - ISO 9001 & 13485 Certified - Call 888-673-5151

Oxford Instruments Service, is a leading ISO 9001 & 13485-certified organization,that specializes in providing quality after-market GE CT and MRI systems, serviceand parts - at prices you can afford.



According to the Advisory Board Company, a global research and consulting firm, this translates into a 32 percent decrease in revenues from an average of $35,917 per patient in 2012 to a projected average of $24,565 per patient for 2013.

All other radiation therapy techniques, like stereotactic body radiosurgery (SBRT) and intensity modulated radiation therapy (IMRT), will be reimbursed only slightly lower than in 2012, according to the new rule for 2013.

The Centers for Medicare and Medicaid Services released the proposed rule this summer. During the comment period, stakeholders argued that the decrease in the cost of proton therapy was due to flawed and incorrect data by one hospital during 2010 and 2011. The University of Pennsylvania's proton therapy center owned up to the mistake and tried to get CMS to fix the data. However, the agency decided not to take that into account for 2013, and stuck by what it originally proposed.

On Nov. 7, the American College of Radiology submitted comments to CMS about the final rule, urging them not to go forward with the proposed cuts for 2013, "due to the concern that some of the data used in CMS' analysis was not representative of proton beam therapy's true costs," stated the letter.

Leonard Arzt, executive director of the National Association for Proton Therapy, said any reimbursement reductions either by Medicare or private insurers could have serious future implications for cancer patients seeking and demanding proton therapy.

CMS published the final rule on Nov. 15.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED